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Abstract The open reading frame YGL087c in the budding
yeast Saccharomyces cerevisiae genome encodes a polypeptide
highly similar to the human UEV (ubiquitin-conjugating E2
enzyme variant) proteins, which have been proposed to belong to
a family of putative dominant negative ubiquitin regulators.
Deletion of the YGL087c open reading frame yields viable cells
which are sensitive to UV irradiation or methyl methanesulfo-
nate, but not to hydroxyurea. This phenotype is reminiscent of
that of rad mutants and suggests that the YGL087c-encoded
protein functions in a process related to tolerance to DNA
damage. We also show that the mutant phenotype is fully
complemented by expression of the human UEV-1A cDNA and
we propose that UEV-1 proteins could also have a role in
protecting higher eukaryotic cells from DNA damaging agents.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The newly described proteins known as UEV (ubiquitin-
conjugating E2 enzyme variant [1]) are de¢ned as proteins
similar in sequence and structure to the E2 ubiquitin-conju-
gating enzymes, but devoid of their enzymatic activity, since
they lack a critical Cys residue essential for the conjugation
and transfer of ubiquitin to substrates [1]. On the basis of
these structural features, it has been proposed that UEV
and related proteins, which include the product of the tumor
suppressor gene TSG101 [2,3], could be novel regulators of
protein ubiquitination, possibly in the form of dominant neg-
ative variants of E2 enzymes [1,4,5]. Although the precise
molecular mechanisms have not been elucidated, UEV pro-
teins exert speci¢c functions in mammalian cells, including cell
cycle regulation [1] and transcriptional control [6]. Further
interest in this novel class of proteins has been stimulated
by the implication of TSG101 in human neoplasia [3,7,8].
UEV proteins are highly conserved in phylogeny, being
present in all eukaryotic organisms. The YGL087c open read-
ing frame of the budding yeast Saccharomyces cerevisiae is
located on chromosome VII [9], encodes a protein with 38%
identity to human UEV-1A [1], and maintains the same struc-
tural features of this class of proteins. This signi¢cant degree
of conservation allows to predict that some of the functions
performed by UEV proteins could be maintained between
distant organisms. Here, we describe the ¢rst steps in the
analysis of the function of the UEV homologue in S. cerevi-
siae, by means of disruption of the YGL087c gene and com-
plementation with cDNA corresponding to human UEV-1A.
We postulate that the product of the yeast gene YGL087c is a
homologue of human UEV-1A [1], and functions to protect
yeast cells from DNA damage. We further propose that this
function is maintained in higher organisms.
2. Materials and methods
2.1. Growth of Escherichia coli and yeast strains
E. coli cells (strain NM522) were grown in LB medium (containing
50 Wg/ml ampicillin, when needed for plasmid selection) at 37‡C.
Yeast cells were grown at 28‡C on YPD medium or, when indicated,
on SD medium [10]. Yeast strains used in this work derive from wild-
type strain BMA64-1A (mat a ura3-1 trp1-v2 leu2-3,112 his3-11 ade1-
1 can1-100), an haploid derivative of strain W303.
2.2. Recombinant DNA techniques, generation of mutant strains
and plasmids construction
E. coli cells were transformed using standard calcium chloride tech-
niques. Yeast cells were transformed by a modi¢cation of the lithium
acetate method [11]. Restriction reactions, DNA ligations and other
standard recombinant techniques were carried out essentially as de-
scribed [12].
Deletion of the entire open reading frame of YGL087c was accom-
plished by the short £anking homology replacement technique [13].
The heterologous marker kanMX4, that contains the kanr gene of
transposon Tn903, was ampli¢ed by PCR from plasmid pFA6-
KanMX4 using oligonucleotides S1-087c (5P-GGAATGCTGC-
AAATACTGTTTAGGAAAAAGTAGATAACTACGTACGCTGC-
AGGTCGA-3P) and S2-087c (5P- TATATGCAACGTAGAAGA-
AAGCAGCGTTTACACAAAAATGATCGATGAATTCGAGCTC-
G-3P). These oligonucleotides were designed to precisely replace the
entire ORF of YGL087c. Underlined sequences correspond to ge-
nomic YGL087c sequence. The stop codon and the Met initiating
triplet are indicated in italics. Three Wg of DNA were used to trans-
form BMA64-1A cells and positives were selected from YPD plates
containing 200 Wg/ml of geneticin (G418). The correct integration of
the marker in the genome was assessed by PCR using oligonucleotides
A1-087c (5P-GCGAATTCGTAACACGTACAGTATC-3P), and A4-
087c (5P-GCGGATCCAAGAAAGGAGAGGACC-3P), correspond-
ing to regions upstream and downstream, respectively, in the chromo-
somal sequence. Underlined sequences correspond to EcoRI and Bam-
HI sites added to facilitate cloning. These oligonucleotides were
combined with oligonucleotides 5P-CACGTCAAGACTGTCAAG-
GA-3P, and 5P-GTTAAGTGCGCAGAAAGTAA-3P, that hybridize
within the marker.
A 1.2 kbp fragment of genomic DNA containing the YGL087c
ORF and £anking regions was ampli¢ed by PCR from wild-type cells
using oligonucleotides A1-087c and A4-087c, digested with EcoRI and
FEBS 19828 17-2-98
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 0 0 6 0 - X
*Corresponding author. Fax: +34 (3) 5812006.
E-mail: J.Arino@cc.uab.es
Abbreviations: HU, hydroxyurea; MMS, methyl methanesulfonate;
ORF, open reading frame; PCR, polymerase chain reaction; UV,
ultraviolet light
FEBS 19828 FEBS Letters 423 (1998) 49^52
BamHI and cloned into the low-copy, centromeric plasmid pRS416
[14], previously linearized with the same enzymes. The human UEV-
1A ORF was expressed in yeast cells by cloning it, downstream of the
GAL1 promoter, into plasmid pYES 2.0 (Invitrogen). To this end, the
entire coding sequence of UEV-1A was ampli¢ed by reverse transcrip-
tase-PCR using total RNA from the HT-29 cell line and oligonucleo-
tides 5P-ATGCCAGGAGAGGTTCAAGCGTCTT-3P and 5P-TTAA-
TTGCTGTAACACTGTCCTTC-3P. Sequences in italics correspond
to the initiating Met and stop codons, respectively. Ampli¢cation was
carried out using Vent DNA polymerase (New England Biolabs). An
additional 15 min treatment with Taq DNA polymerase was per-
formed to create overhanging ends, and the ampli¢ed DNA was
cloned into the pGEM-T vector (Promega) and sequenced (both
strands). The construct was digested with SacI and SphI and cloned
in these same sites of pYES 2.0 to yield plasmid pYES/UEV1-A.
2.3. Survival determination after UV irradiation, MMS and HU
treatments
For all treatments, exponential cells were grown on SD medium
lacking uracil to a density of 1^1.5. For UV irradiation, cells were
diluted in the same medium and a volume of 200 Wl was plated. Plates
were irradiated at the indicated doses in a Stratalinker UV crosslinker
(Stratagene) and incubated at 30‡C for 48 to 72 h in the dark. Col-
onies were counted and the percentage of survival determined by
comparison with the unirradiated control plates.
For MMS treatment, cultures were incubated for the indicated
times in the presence or absence of 0.05% MMS at 30‡C. Following
the incubation, cells were plated on SD lacking uracil plates, incu-
bated at 30‡C, and colonies counted after 48^72 h. The percentage of
survival was determined by comparison with untreated control cells.
HU treatment was similar to MMS treatment but cells were incubated
in the presence or absence of 0.2 M HU for 3 h.
3. Results and discussion
A new class of proteins that could function as regulators of
protein ubiquitination has been recently identi¢ed. Based on
sequence alignments and molecular modeling analysis, it has
been proposed that UEV-1/CROC-1 [1,6] and the protein en-
coded by the human tumor suppressor gene TSG101 [2] are
inactive variants of the E2 ubiquitin-conjugating enzymes
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Fig. 1. A: Alignment of human UEV-1A/CROC-1A and its related human and yeast proteins with ubiquitin-conjugating enzymes (UBC) and
TSG101-related proteins. The carboxyl-terminal domains of the UBC and TSG101 proteins are not represented in the alignment. B: Dendo-
gram of phylogenetic relationships corresponding to the sequences aligned in A. The mean distances between the three subfamilies of proteins
are: UEV/UBC, 0.77 ( þ 0.03); TSG101/UBC, 0.79 ( þ 0.04); UEV/TSG101, 0.85 ( þ 0.04). Alignments and dendograms were generated with
ClustalW and PHILIP packages.
Fig. 2. Deletion of the yeast gene YGL087c, a putative dominant
negative ubiquitin regulator, results in hypersensitivity to DNA
damaging agents. The complete YGL087c ORF was precisely de-
leted and replaced by the kanMX4 module as described in the hap-
loid S. cerevisiae strain BMA64-1A. Wild-type cells (b), deletion
mutant (S) (both carrying the centromeric plasmid pRS416), or
mutants carrying a wild-type copy of the YGL087c gene in pRS416
(F), were grown in SD medium lacking uracil (plus 2% glucose) un-
til an optical density of 0.8^1.2. UV irradiation, and MMS and HU
treatments were as described in Section 2. Results are expressed as
percentages referred to untreated cells and are means þ S.E.M.
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[1,4,5]. Although their predicted structures are very similar, a
more detailed analysis shows that UEV-1A and the product of
TSG101 belong to distinct subfamilies of proteins, which are
phylogenetically equidistant from the catalytically active E2
proteins (Fig. 1).
The study of the biological role of ORF YGL087c was
carried out by generating deletion mutants. Replacement of
the entire coding region by the kanamycin marker yielded
viable cells, indicating that YGL087c is not an essential
gene. Mutant cells could not be distinguished from wild-type
cells when a number of growth conditions were tested (di¡er-
ent carbon sources, temperatures, and exposure to salt, caf-
feine or calco£uor). However, mutant cells showed a clear
increase in their sensitivity to UV irradiation. The sensitivity
to UV of mutant cells was reduced when a copy of the gene
was placed in the centromeric plasmid pRS416 (Fig. 2). Mu-
tant cells were also highly sensitive to the DNA damaging
agent MMS, but they did not display a signi¢cant di¡erence
in sensitivity, as compared to wild-type cells, when they were
exposed to HU for 3 h (Fig. 2). This di¡erence in behavior is
of biological signi¢cance, since UV and MMS negatively af-
fect cell growth through alterations in the structure of DNA
(although by di¡erent mechanisms), while HU acts as an in-
hibitor of ribonucleotide reductase, thus preventing DNA syn-
thesis and progression through the S phase of the cell cycle
(see [15] and references therein).
The fact that human and yeast UEV proteins have common
structural features allows to predict that some of their func-
tions will be conserved. Thus, we sought to test the possibility
that human UEV-1A could function in a S. cerevisiae back-
ground. Yeast mutant cells lacking YGL087c were trans-
formed with the plasmid pYES/UEV-1A, which permits ex-
pression of the human cDNA after shift of the carbon source
from glucose to galactose. It can be seen that the sensitivity to
both UV and MMS of mutant cells expressing human UEV-
1A reverted to wild-type levels (Fig. 3).
In summary, the phenotype observed in S. cerevisiae cells
lacking YGL087c is reminiscent of that of rad mutants [16],
and our data indicate that UEV proteins function in processes
related to tolerance to DNA damage. The observed role in
DNA repair/tolerance of YGL087c, a potential regulator of
ubiquitination, suggests that it could interact, directly or in-
directly, with active ubiquitinating enzymes that promote
DNA repair. For instance, the E2 ubiquitin-conjugating en-
zymes Rad6 [17] and Ubc9 [18,19] and a mammalian E1 ubiq-
uitin-activating enzyme [20], play critical roles in DNA dam-
age repair/tolerance. It is conceivable that YGL087c exerts its
protective e¡ects against DNA damage through physical or
functional interactions with one or more of such proteins.
Alternatively, this protein could be involved in a separate
pathway regulating DNA damage repair/tolerance in S. cere-
visiae.
The complementation by human UEV-1A of the S. cerevi-
siae YGL087c mutant phenotype indicates that UEV proteins
from distant organisms have similar functions. Therefore, we
propose that human UEV-1A could also have a role in pro-
tecting higher eukaryotic cells from DNA damaging agents.
Expression of UEV-1A in human cells is cell cycle regulated,
and its unregulated expression from a constitutive promoter
leads to the inhibition of the mitotic kinase Cdk1 and arrest in
the G2-M phase of the cell division cycle [1]. Such observa-
tions provide an indirect support for the involvement of UEV-
1A in the regulation of a G2-M checkpoint, similar to that
activated in response to DNA damage [16].
While so far the gene for UEV-1 has not been implicated in
human disease, structural alterations or abnormal expression
of TSG101 have been reported in breast cancer [3,7,8]. Our
¢ndings provide the ¢rst evidence linking this new class of
proteins to protection from DNA damage, and might estab-
lish the basis for unraveling novel mechanisms of human tu-
morigenesis. A possible scenario would be one in which loss
of function of UEV-1 could lead to an increased rate of muta-
genesis, therefore contributing to the establishment, mainte-
nance and/or progression of the neoplastic phenotype.
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